Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of September 2019. The document serves as a transaction notification regarding insider trading activity rather than a periodic financial report.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the transaction price of American Depositary Shares (ADSs) at $41.75 per share.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses a specific securities transaction executed on August 30, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a regulatory disclosure of a purchase transaction.
Important Facts for Investors
- Transaction Type: Purchase of 1,800 American Depositary Shares (ADSs).
- Parties Involved: Ms. D Conrad (SVP, Human Resources) and Mr. C J Conrad (Person Closely Associated).
- Transaction Date: August 30, 2019.
- Transaction Price: $41.75 per ADS.
- Exchange: New York Stock Exchange (XNYS).
- Reporting Date: September 4, 2019.